The firm's first candidate, AP003, will focus on rare genetic liver diseases caused by nonsense mutations that prematurely ...
Alltrna is advancing a new class of genetic medicines based on the power of tRNA biology to universally treat Stop Codon Disease, which encompasses thousands of genetic diseases caused by a premature ...